Search results
Author(s):
Constantinos O’Mahony
,
Saidi Mohiddin
,
Charles Knight
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM) is a genetic disorder of cardiac muscle with a heterogeneous clinical course.1 The disease is clinically characterised by left ventricular hypertrophy (LVH), which is typically asymmetric, and a subgroup of patients have left ventricular outflow tract obstruction (LVOTO) caused by systolic anterior motion (SAM) of the mitral valve leaflet(s).2,3 LVOTO is often…
View more
Author(s):
Priya Bansal
,
Hamza Lodhi
,
Adithya Mathews
,
et al
Added:
2 years ago
Eduardo A Arias
Research Area(s) / Expertise:
Author
Liam McCormick
Research Area(s) / Expertise:
Job title: Interventional & Structural Cardiologist
Author
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Transseptal Mitral Valve Therapy
Author(s):
Marvin H Eng
,
Dee Dee Wang
Added:
3 years ago
Article
Annapoorna Kini
Job title: The Mount Sinai Hospital
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
Trials covered in detail include:
00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice.
Trials covered in detail include:
00:29: PACMAN AMI:…
View more
Author(s):
Timothy Glenie
,
Peter Ruygrok
Added:
3 years ago
Abstract
As the treatment of acute myocardial infarction has evolved from conservative management to thrombolysis and, in more recent times, primary angioplasty, the incidence of ventricular rupture, in particular post-infarction ventricular septal defect (VSD), appears to have fallen. In this article we discuss the clinical presentation and investigation of post-infarction VSD, the natural…
View more